Researchers determined patients with paroxysmal hemoglobinuria may benefit from receiving ravulizumab over the long term.

Due to its rarity, the exact incidence is unknown, however, it is estimated that the global prevalence is 15.9 individuals per one million people. The PIGA mutation in PNH causes red blood cells ...

The prevalence of PNH in the UK is estimated to be 1.59 per 100,000 individuals. "We are working with the [National PNH Service] to incorporate PiaSky into the patient pathway and we remain ...

Teva and Samsung Bioepis have launched Epysqli, a cost-saving Soliris biosimilar, offering a 30% discount and new hope for ...